留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

miR-130b-3p促进人牙源性iPSCs重编程的作用

谭小兵 张敏 郭宇 杜琳玲 戴青原

谭小兵, 张敏, 郭宇, 杜琳玲, 戴青原. miR-130b-3p促进人牙源性iPSCs重编程的作用[J]. 昆明医科大学学报, 2022, 43(12): 18-22. doi: 10.12259/j.issn.2095-610X.S20221204
引用本文: 谭小兵, 张敏, 郭宇, 杜琳玲, 戴青原. miR-130b-3p促进人牙源性iPSCs重编程的作用[J]. 昆明医科大学学报, 2022, 43(12): 18-22. doi: 10.12259/j.issn.2095-610X.S20221204
Xiaobing TAN, Min ZHANG, Yu GUO, Linling DU, Qingyuan DAI. Effect of miR-130b-3p on the Reprogramming of Human Dental Origin iPSCs[J]. Journal of Kunming Medical University, 2022, 43(12): 18-22. doi: 10.12259/j.issn.2095-610X.S20221204
Citation: Xiaobing TAN, Min ZHANG, Yu GUO, Linling DU, Qingyuan DAI. Effect of miR-130b-3p on the Reprogramming of Human Dental Origin iPSCs[J]. Journal of Kunming Medical University, 2022, 43(12): 18-22. doi: 10.12259/j.issn.2095-610X.S20221204

miR-130b-3p促进人牙源性iPSCs重编程的作用

doi: 10.12259/j.issn.2095-610X.S20221204
基金项目: 云南省科技厅-昆明医科大学应用基础研究联合专项基金资助项目[2019FE001(-113)];云南省高层次卫生计生技术人才培养经费基金资助项目(D-2018045)
详细信息
    作者简介:

    谭小兵(1974~),男,山西运城人,医学硕士,副主任医师,主要从事牙体牙髓病的研究工作

    通讯作者:

    戴青原,E-mail:dqy0823@163.com

  • 中图分类号: R781

Effect of miR-130b-3p on the Reprogramming of Human Dental Origin iPSCs

  • 摘要:   目的  研究hsa-miR-130b-3p对人DPSCs重编程为iPSCs的影响。  方法  设计合成LV3(H1/GFP&Puro)-hsa-miR-130b-3p-mimics质粒,Lipofectamine 3000将质粒转染到人DPSCs,荧光显微镜观察细胞,RT-qPCR验证转染效率。Sendai reprogramming kit将2组DPSCs重编程为iPSCs(实验组为miR-130b-3p-DPSCs,对照组为DPSCs),对比2组iPSCs克隆形态和重编程效率,RT-PCR检测Oct4、Nanog、KOS、Klf4、c-Myc的表达。  结果  hsa-miR-130b-3p过表达质粒转染48 h后在DPSCs内有明显表达,证实高效的转染效率(P < 0.01)。Sev重编程得到的2组iPSCs均呈现为扁平致密的圆形克隆,边缘清晰平滑,集落内细胞形态均一、核质比较大,RT-PCR结果表明2组细胞均可表达干细胞特异标志物Oct4和Nanog,同时外源性病毒SeV或转录因子KOS/Klf4/c-Myc不再表达。实验组的重编程效率高于对照组(分别为0.037%和0.018%,P < 0.05)。  结论  hsa-miR-130b-3p可明显促进人DPSCs重编程的效率,为iPSCs应用于牙髓再生治疗提供研究基础。
  • 图  1  miR-130b-3p-mimics转染DPSCs效率验证

    A:miR-130b-3p空载组;B:miR-130b-3p-mimics组;C:2组细胞miR-130b-3p表达的q-PCR检测。**P < 0.01。

    Figure  1.  Validation of DPSCs transfection efficiency by miR-130b-3p-mimics

    图  2  2组iPSCs克隆形态和特异性标记物的表达

    A:DPSCs细胞形态(×100);B:正常DPSCs-iPSCs克隆;C:miR-130b-3p-DPSCs-iPSCs克隆(标尺 = 100 μm);D:2组iPSCs特异性标记物的RT-PCR结果。

    Figure  2.  Morphology and specific markers expression of iPSCs in two groups

    表  1  RT-PCR特异性引物的序列

    Table  1.   Specific primer sequences of RT-PCR

    基因引物序列(5′-3′)
    Sev Forward GGATCACTAGGTGATATCGAGC
    Reverse ACCAGACAAGAGTTTAAGAGA
    Klf4 Forward TTCCTGCATGCCAGAGGAGCCC
    Reverse AATGTATCGAAGGTGCTCAA
    Myc Forward TAACTGACTAGCAGGCTTGTCG
    Reverse TCCACATACAGTCCTGGATGAT
    KOS Forward ATGCACCGCTACGACGTGAGGGC
    Reverse ACCTTGACAATCCTGATGTGG
    Oct4 Forward GAAGGTATTCAGCCAAACGAC
    Reverse GTTACAGAACCACACTCGGA
    Nanog Forward TGCAAATGTCTTCTGCTGAGAT
    Reverse GTTCAGGATGTTGGAGAGTTC
    Gapdh Forward GGAGCGAGATCCCTCCAAAAT
    Reverse GGCTGTTGTCATACTTCTCATGG
    下载: 导出CSV
  • [1] Takahashi K,Tanabe K,Ohnuki M,et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors[J]. Cell,2007,131(5):861-872. doi: 10.1016/j.cell.2007.11.019
    [2] Yu J,Vodyanik M A,Smuga-Otto K,et al. Induced pluripotent stem cell lines derived from human somatic cells[J]. Science,2007,318(5858):1917-1920. doi: 10.1126/science.1151526
    [3] Hu J,Wang J. From embryonic stem cells to induced pluripotent stem cells-Ready for clinical therapy?[J]. Clin Transplant,2019,33(6):e13573.
    [4] Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges[J]. Cell Stem Cell,2020,27(4):523-531. doi: 10.1016/j.stem.2020.09.014
    [5] Liu G,David B T,Trawczynski M,et al. Advances in pluripotent stem cells:History,mechanisms,technologies,and applications[J]. Stem Cell Rev Rep,2020,16(1):3-32. doi: 10.1007/s12015-019-09935-x
    [6] Zeng Z L,Lin X L,Tan L L,et al. MicroRNAs:Important regulators of induced pluripotent stem cell generation and differentiation[J]. Stem Cell Rev Rep,2018,14(1):71-81. doi: 10.1007/s12015-017-9785-6
    [7] Zou X Y,Yang H Y,Yu Z,et al. Establishment of transgene-free induced pluripotent stem cells reprogrammed from human stem cells of apical papilla for neural differentiation[J]. Stem Cell Res Ther,2012,3(5):43. doi: 10.1186/scrt134
    [8] Tan X,Dai Q. Characterization of microRNAs expression profiles in human dental-derived pluripotent stem cells[J]. PLoS One,2017,12(5):e0177832. doi: 10.1371/journal.pone.0177832
    [9] Guo Q,Zhu X,Wei R,et al. miR-130b-3p regulates M1 macrophage polarization via targeting IRF1[J]. J Cell Physiol,2021,236(3):2008-2022. doi: 10.1002/jcp.29987
    [10] Song D,Zhang Q,Zhang H,et al. MiR-130b-3p promotes colorectal cancer progression by targeting CHD9[J]. Cell Cycle,2022,21(6):585-601. doi: 10.1080/15384101.2022.2029240
    [11] Ye H,Wang Q. Efficient generation of non-integration and feeder-free induced pluripotent stem cells from human peripheral blood cells by Sendai virus[J]. Cell Physiol Biochem,2018,50(4):1318-1331.
    [12] Okumura T,Horie Y,Lai CY,et al. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34+ cells using the auto-erasable Sendai virus vector[J]. Stem Cell Res Ther,2019,10(1):185. doi: 10.1186/s13287-019-1273-2
    [13] Lin S L,Chen J S,Ying S Y. MiR-302-mediated somatic cell reprogramming and method for generating tumor-free iPS cells using miR-302[J]. Methods Mol Biol,2020,2115:199-219.
    [14] Lin S L,Chang D,Lin C H,et al. Regulation of somatic cell reprogramming through inducible mir-302 expression[J]. Nucleic Acids Res,2011,39(3):1054-1065. doi: 10.1093/nar/gkq850
    [15] Anokye-Danso F,Trivedi C M,Juhr D,et al. Highly efficient miRNAmediated reprogramming of mouse and human somatic cells to pluripotency[J]. Cell Stem Cell,2011,8(4):376-388. doi: 10.1016/j.stem.2011.03.001
    [16] Miyoshi N,Ishii H,Nagano H,et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs[J]. Cell Stem Cell,2011,8(6):633-638. doi: 10.1016/j.stem.2011.05.001
    [17] Pascale E,Caiazza C,Paladino M,et al. MicroRNA roles in cell reprogramming mechanisms[J]. Cells,2022,11(6):940. doi: 10.3390/cells11060940
    [18] Lim J,Sakai E,Sakurai F,et al. miR-27b antagonizes BMP signaling in early differentiation of human induced pluripotent stem cells[J]. Sci Rep,2021,11(1):19820. doi: 10.1038/s41598-021-99403-9
    [19] Yue W,Sun J,Zhang J,et al. Mir-34c affects the proliferation and pluripotency of porcine induced pluripotent stem cell (piPSC)-like cells by targeting c-Myc[J]. Cells Dev,2021,166:203665.
  • [1] 邓勇军, 陈倩, 邹建彬, 宫政, 刘焕鹏.  ZIC1基因过表达激活P53信号通路抑制胸膜间皮瘤细胞增殖, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240405
    [2] 徐倩, 崔玉梅, 马思明, 林云红, 熊依菁, 宋子珺, 李旭东.  miR-148a-3p靶向SMURF2调节牙髓干细胞和口腔上皮细胞共培养体系成骨分化及牙釉质发育的作用机制, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231103
    [3] 李春桃, 张雪梅, 苏琰迪, 张剑青.  过表达及敲减LncRNA RP11-521C20.3的非小细胞肺癌A549稳转细胞株的构建, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20231016
    [4] 李婷, 郭维华.  糖酵解重编程在口腔鳞状细胞癌中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230611
    [5] 钱石兵, 张凌鹏, 殷凌云, 李昌全, 李虎, 于鸿滨.  不同浓度的牙髓干细胞成骨能力的研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230214
    [6] 张素仙, 冯莉嵋, 伍路, 杨绍艳, 赵庆华.  miR-145通过调控人子宫内膜基质细胞OCT4的表达促进子宫内膜异位症的发展机制, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220220
    [7] 铁金杉, 刘垚, 陈绍春.  星形胶质细胞-神经元转化体内诱导研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210333
    [8] 魏韩笑, 张爱君, 李强, 金培生.  血管内皮祖细胞外泌体调控骨髓间充质干细胞基因表达谱芯片, 昆明医科大学学报.
    [9] 赵斌, 李瑞乾, 张国颖, 雷永虹, 王启林, 刘志敏.  过表达miR-4328抑制前列腺癌细胞的增殖、迁移和上皮间质转化, 昆明医科大学学报.
    [10] 戈佳云.  慢病毒介导的FHIT基因过表达调控人肝癌细胞株生长实验研究, 昆明医科大学学报.
    [11] 魏东.  重组pcDNA 3.0-WWOX构建对胆囊癌细胞表达及△Ψm的影响, 昆明医科大学学报.
    [12] 路萍.  白血病患者化疗前后调节性T细胞的表达与微小残留白血病的关系, 昆明医科大学学报.
    [13] 韩群超.  人牙髓干细胞的体外分离、培养及鉴定, 昆明医科大学学报.
    [14] 黄云燕.  多氯联苯对胎鼠神经干细胞Nnat基因表达的影响, 昆明医科大学学报.
    [15] 戚宗泽.  兔骨髓间充质干细胞的分离、体外培养、鉴定及成脂诱导, 昆明医科大学学报.
    [16] 焦扬.  羊水干细胞体外培养早期和后期基因表达谱分析, 昆明医科大学学报.
    [17] 陈绍春.  用慢病毒转染技术实现Gnaq基因在SH-SY5Y细胞中持续稳定高表, 昆明医科大学学报.
    [18] 武斌.  大豆苷元对人乳牙牙髓干细胞增殖和成骨分化的影响, 昆明医科大学学报.
    [19] 体外培养神经干细胞CNTF、TGF-β1和IGF-1的表达, 昆明医科大学学报.
    [20] 丁鹏.  新生大鼠海马神经干细胞表达趋化因子受体CCR2的体外研究, 昆明医科大学学报.
  • 加载中
图(2) / 表(1)
计量
  • 文章访问数:  3030
  • HTML全文浏览量:  1982
  • PDF下载量:  14
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-07-27
  • 网络出版日期:  2022-12-05
  • 刊出日期:  2022-12-25

目录

    /

    返回文章
    返回